BioScale's Series B Round

BioScale raised a round of funding on February 10, 2005. Investors include F2 Ventures.

BioScale develops, manufactures and promotes a protein measurement technology to accelerate drug discovery, development and production of biological and pharmaceutical products. The company enables cu…

Articles about BioScale's Series B Round: